Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $472.05 ($4.5M) on 2026-09-29, disclosed to the SEC on 2026-09-30.
Scheduled sale ($4.5M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $472.05 | 400 | $189K | 4.2% |
| 2 | $472.97 | 449 | $212K | 4.7% |
| 3 | $473.86 | 80 | $38K | 0.8% |
| 4 | $475.12 | 552 | $262K | 5.8% |
| 5 | $476.10 | 1,395 | $664K | 14.6% |
| 6 | $477.09 | 2,135 |
| $1.0M |
| 22.5% |
| 7 | $478.10 | 2,309 | $1.1M | 24.3% |
| 8 | $479.07 | 1,200 | $575K | 12.7% |
| 9 | $479.59 | 160 | $77K | 1.7% |
| 10 | $481.22 | 500 | $241K | 5.3% |
| 11 | $482.28 | 120 | $58K | 1.3% |
| 12 | $486.77 | 200 | $97K | 2.1% |
| Total | $477.42 avg | 9,500 | $4.5M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-09 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-08 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-07 | $5.1M | — | Filing → |